These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23577655)

  • 1. Methamphetamine-associated psychosis: a new health challenge in Iran.
    Alam Mehrjerdi Z; Barr AM; Noroozi A
    Daru; 2013 Apr; 21(1):30. PubMed ID: 23577655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal in Iran: methamphetamine or heroin kerack.
    Alam Mehrjerdi Z
    Daru; 2013 Mar; 21(1):22. PubMed ID: 23497450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country.
    Alam-mehrjerdi Z; Mokri A; Dolan K
    Asian J Psychiatr; 2015 Aug; 16():17-25. PubMed ID: 26123235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options.
    Chiang M; Lombardi D; Du J; Makrum U; Sitthichai R; Harrington A; Shukair N; Zhao M; Fan X
    Hum Psychopharmacol; 2019 Sep; 34(5):e2710. PubMed ID: 31441135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of inpatients with methamphetamine-induced psychosis.
    Fasihpour B; Molavi S; Shariat SV
    J Ment Health; 2013 Aug; 22(4):341-9. PubMed ID: 23323572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country.
    Alam-Mehrjerdi Z; Abdollahi M
    Daru; 2015 Nov; 23():51. PubMed ID: 26578071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review and Meta-Analysis of the Prevalence of Methamphetamine Abuse in Iranian High School Students.
    Sayyah M; Shirbandi K; Javanmardi F; Rahim F
    J Med Life; 2018; 11(4):262-268. PubMed ID: 30894880
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of clinical toxicology education and ethics in medical care of poisoned patients in the Islamic Republic of Iran and a comparison with other countries.
    Banagozar-Mohammadi A; Delirrad M; Alizadeh A; Majidi M; Balali-Mood M
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):475-483. PubMed ID: 31863569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study.
    Samiei M; Vahidi M; Rezaee O; Yaraghchi A; Daneshmand R
    Iran J Psychiatry Behav Sci; 2016 Sep; 10(3):e7988. PubMed ID: 27822286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared decision making in Iran: Current and future trends.
    Rahimi SA; Alizadeh M; Légaré F
    Z Evid Fortbild Qual Gesundhwes; 2017 Jun; 123-124():52-55. PubMed ID: 28549749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is the Japanese mental health service lacking for drug dependence rehabilitation?].
    Matsumoto T; Kobayashi O
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):172-87. PubMed ID: 18646643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
    Tucker MG; Kekulawala S; Kent M; Mostafa S; Harvey R
    J Med Case Rep; 2016 Sep; 10(1):242. PubMed ID: 27599617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine Use among Iranian Youth: A Population-based Knowledge, Attitude, and Practice study.
    Sharifi H; Shokoohi M; Ahmad RafieiRad A; Sargolzaie Moghadam M; Haghdoost AA; Mirzazadeh A; Karamouzian M
    Subst Use Misuse; 2017 Jul; 52(9):1232-1239. PubMed ID: 28605272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
    Yui K; Ikemoto S; Ishiguro T; Goto K
    Ann N Y Acad Sci; 2000 Sep; 914():1-12. PubMed ID: 11085303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
    Alammehrjerdi Z; Ezard N; Dolan K
    Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-urgent visits to emergency departments: a qualitative study in Iran exploring causes, consequences and solutions.
    Bahadori M; Mousavi SM; Teymourzadeh E; Ravangard R
    BMJ Open; 2020 Feb; 10(2):e028257. PubMed ID: 32051293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.